Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, December 18, 2013

NIH Announces Funding for Concussion-Related Research

Not a single one looks at pretreatment with fish oil or post-treatment with fish oil.
Does no one read previous research at all?
http://www.medscape.com/viewarticle/817999
The 8 projects as Medscape reports them.
  • CTE and Post-traumatic Neurodegeneration: Neuropathology and Ex Vivo Imaging. Under Principal Investigator Ann C. McKee, MD, Boston University School of Medicine and U.S. Department of Veterans Affairs, Massachusetts, this project's goals include defining a clear set of criteria for the various stages of CTE and to distinguish it from Alzheimer's disease, amyotrophic lateral sclerosis, and other neurodegenerative disorders in postmortem brain tissue. Once these characteristics have been defined in brain tissue, imaging teams will correlate them with brain scans to identify features that might eventually be used to diagnose CTE in individuals during their lifetimes.
  • Neuropathology of CTE and Delayed Effects of TBI: Toward In Vivo Diagnostics. The goal of this project, under principal investigator Wayne Gordon, PhD, Mount Sinai Hospital in New York, is to identify and describe the chronic effects of mild, moderate, and severe TBIs and compare these with the features of CTE. Dr. Gordon and his colleagues will evaluate brain tissue obtained from an ongoing study of thousands of people (the Adult Changes in Thought study) and will examine brain tissue from donors who sustained severe TBI. Neuroimaging teams at various centers will use sophisticated brain scanning techniques in patients with a range of head injuries, as well as on postmortem tissue, to identify potential markers that may eventually be used to diagnose the degenerative effects of TBI.
    • Cortical GABA in Pediatric Sports Concussion (Principal Investigator: Jeffrey G. Ojemann, MD, Seattle Children's Hospital, Washington). Gamma-aminobutyric acid (GABA) is important for cognition and movement and may be altered by TBI. The aim of this project is to use magnetic resonance (MR) spectroscopy to monitor GABA levels in adolescents who have sports-related concussions and compare those levels with those in uninjured controls. The researchers will also conduct preliminary comparisons of GABA levels with existing cognitive measures, such as memory tests and structural brain imaging.
    • Evaluation of Spot Light: A Concussion Injury Management App for Youth Sports (Principal Investigators: Lara McKenzie, PhD, Center for Injury Research and Policy, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, and Dawn Comstock, PhD, Colorado School of Public Health, University of Colorado, Denver). The goal of this project is to test the effectiveness of Spot Light, an easy-to-use mobile application (or app), developed by Inlightened. The app was designed to help doctors, coaches, and others track the progress of a young athlete from the time of a concussion until he or she is cleared to return to play. The researchers want to know whether the app will result in more concussions being reported, increased referrals to doctors, and better adherence to return-to-play guidelines.
    • Eye Movement Dynamics: A Rapid Objective Involuntary Measure of Concussion/Mild Traumatic Brain Injury (Principal Investigators: Nicholas Port, PhD, and Steven Hitzeman, OD, Indiana University School of Optometry, Bloomington). In collaboration with others, the investigators will develop a portable eye-tracking instrument to help diagnose concussions on the sidelines and to monitor injury progression in young athletes. They will compare the eye-tracking data to results from a commonly used cognitive test to determine whether changes in eye movement can serve as a biomarker for sports-related mild TBI.
    • Imaging and Biomarkers in Adolescents Cleared for Return to Play After Concussion (Principal Investigator: Harvey Levin, PhD, Baylor College of Medicine, Houston, Texas). Using a variety of neuroimaging techniques, Dr. Levin and his group will look at the effects of sports-related concussions on brain structure and function 1 month following injury in adolescents who have been cleared to play. In addition, this project will evaluate microRNAs, which are small portions of RNA, as potential biomarkers for concussions and recovery.
    • Somatosensory Processing — Assessing Youth Sport-Related Concussion and Recovery (Principal Investigator: Stacy Jennifer Marcus Suskauer, MD, Kennedy Krieger Institute, Baltimore, Maryland). This research team will use a portable device that delivers vibrations to fingertips to investigate whether somatosensory system information processing (SSIP) could be a biomarker for concussion and recovery in youth ages 13 to 17 years. Perception of the vibrations reflects activity of sensory neurons in the brain, thereby providing a measure of SSIP. The researchers will also investigate whether changes in SSIP are related to differences in certain brain chemicals after head injury.
    • Characterization of the Brain and Serum Metabolome in Mouse Models of Concussion (Principal Investigator: Michael J. Whalen, MD, Massachusetts General Hospital, Boston). This group plans to use an experimental model of TBI to conduct a detailed analysis of changes in the brain metabolome (the collection of all metabolites in the body) following a concussion. The researchers will compare those differences with serum byproducts to determine whether the changes can be revealed in blood samples. The results of this project may help identify potential targets for detecting and treating concussions.

No comments:

Post a Comment